← Evidence map

TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA.

Se-Hoon Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40617394